AFP and hepatocellular carcinoma: Particularly, levels of AFP were increased in HCV patients with occurrence or recurrence of HCC, both before and after the DAA treatment, whereas the expression of AFP-L3% was associated with the occurrence and recurrence of HCC only after DAA therapy [86].